Certara Valuation
| CERT Stock | USD 10.00 0.11 1.09% |
At this time, the firm appears to be undervalued. Certara shows a prevailing Real Value of $10.44 per share. The current price of the firm is $10.0. Our model approximates the value of Certara from analyzing the firm fundamentals such as Return On Equity of 0.0103, current valuation of 1.72 B, and Profit Margin of 0.03 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Certara's price fluctuation is somewhat reliable at this time. Calculation of the real value of Certara is based on 3 months time horizon. Increasing Certara's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Certara's intrinsic value may or may not be the same as its current market price of 10.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.0 | Real 10.44 | Hype 10.0 | Naive 10.4 |
The intrinsic value of Certara's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Certara's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Certara helps investors to forecast how Certara stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Certara more accurately as focusing exclusively on Certara's fundamentals will not take into account other important factors: About Certara Valuation
The stock valuation mechanism determines Certara's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Certara based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Certara. We calculate exposure to Certara's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Certara's related companies.Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. Certara operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1054 people.
Certara Growth Indicators
Investing in growth stocks can be very risky. If the company such as Certara does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 160.4 M | |
| Quarterly Earnings Growth Y O Y | -0.141 | |
| Forward Price Earnings | 19.5313 |
Additional Tools for Certara Stock Analysis
When running Certara's price analysis, check to measure Certara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Certara is operating at the current time. Most of Certara's value examination focuses on studying past and present price action to predict the probability of Certara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Certara's price. Additionally, you may evaluate how the addition of Certara to your portfolios can decrease your overall portfolio volatility.